Related Experiment Video
Updated: Jul 15, 2026

The MultiBac Protein Complex Production Platform at the EMBL
Published on: July 11, 2013
Construction of an engineered Bacillus subtilis for production of poly-γ-glutamic acids with specific molecular
Yu Lin1, Yiwei Ding2, Lin Shu1,3
1Key Laboratory of Molecular Medical Engineering, Education Department of Guangxi Zhuang Autonomous Region, School of Intelligent Medicine and Biotechnology, Guilin Medical University, Guilin, China.
Introduction:
Poly-γ-glutamic acid (γ-PGA) with different molecular weight (Mw) exhibits different properties and therefore has a variety of applications. At present, the γ-PGA is mainly produced by Bacillus species. However, the production of γ-PGAs with specific Mws often requires multiple strains, which limits the development and application of γ-PGA.
Methods:
To address this limitation, we constructed an engineered Bacillus subtilis strain by deleting hydrolase genes cwlO, pgdS and ggt, and further introduced regulation of PgdS expression under an IPTG-inducible promoter.
Results:
When the hydrolase genes cwlO, pgdS and ggt in B. subtilis were deleted, the γ-PGA Mw and titer increased by 220.1% (2.42×107 Da) and 47.81% (8.44 g/L), respectively. Furthermore, regulation of PgdS expression enabled dynamic control of γ-PGA Mw. The γ-PGA with Mw ranging from 9.55×104 Da to 2.15×107 Da was produced by change of IPTG addition time in an engineered strain, with the titer of 6.28-8.57 g/L. In the 5-L fermenter, the γ-PGA with Mw ranging from 8.3×104 Da to 1.87×107 Da was produced under optimal conditions.
Conclusion:
In summary, an engineered strain that can dynamically regulate the γ-PGA Mw and produce γ-PGAs with specific Mws was obtained, and its regulatory range was wider than that of previous studies, which increased the application potential.
More Related Videos
Related Concept Videos
Bioreactor Controls-III
Upstream Processing
Production of Pharmaceuticals
Production of Biopesticides

